Modulatory role of atorvastatin against high-fat diet and zymosan-induced activation of TLR۲/NF-ƙB signaling pathway in C۵۷BL/۶ mice
محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 24، شماره: 8
سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 205
فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJBMS-24-8_003
تاریخ نمایه سازی: 10 شهریور 1400
چکیده مقاله:
Objective(s): Accumulated evidence provides a strong connection between the immune system and vascular inflammation. The innate immune system’s main sensors are toll-like receptors (TLRs). Zymosan (Zym), a fungal product, induces an inflammatory response via activating TLR۲ of the immune system. Atorvastatin, a potent statin, possesses pleiotropic effects including immunomodulatory, lipid-lowering, and anti-inflammatory. Therefore, the current study aimed to evaluate the protective role of atorvastatin against a high-fat diet (HFD) and Zym-induced vascular inflammation in C۵۷BL/۶ mice via modulation of TLR۲/NF-ƙB signaling pathway.Materials and Methods: In silico study was conducted to confirm the binding affinity of atorvastatin against TLR۲. Under in vivo study, mice were divided into four groups: Normal control: normal standard chow-diet fed for ۳۰ days + Zym vehicle (sterile PBS, ۵ mg/ml on ۸th day); HFD (۳۰ days) + Zym (۸۰ mg/kg, IP, on ۸th day); HFD/Zym + atorvastatin vehicle (۰.۵% CMC, p.o., from ۱۰th to ۳۰th day); HFD/Zym + atorvastatin (۳.۶ mg/kg, p.o., from ۱۰th to ۳۰th day).Results: Atorvastatin treatment along with HFD and Zym inhibited vascular inflammation by suppressing the levels of aortic TLR۲, cardiac NF-ƙB and decrease in serum TNF-α and IL-۶. Further, there was an increase in hepatic LDLR levels, resulting in a decrease in serum LDL-C and an increase in HDL-C levels. Histopathological examination of the aorta showed a reduction in plaque accumulation with the atorvastatin-treated group as compared with HFD and Zym-treated group.Conclusion: Atorvastatin attenuates vascular inflammation mediated by HFD and Zym through suppression of TLR۲, NF-ƙB, TNF-α, IL-۶, and upregulation of LDLR levels.
کلیدواژه ها:
Atorvastatin High ، fat diet Inflammation Low ، density lipoprotein ، receptor Nuclear factor ، kappa B Toll ، like receptor Zymosan
نویسندگان
Priyanka Arya
Department of Pharmacology, School of Pharmaceutical Education & Research (SPER), Jamia Hamdard (UGC approved deemed to be University, Govt. of India), New Delhi- ۱۱۰۰۶۲, India
Sayima Nabi
Department of Pharmacology, School of Pharmaceutical Education & Research (SPER), Jamia Hamdard (UGC approved deemed to be University, Govt. of India), New Delhi- ۱۱۰۰۶۲, India
Uma Bhandari
Department of Pharmacology, School of Pharmaceutical Education & Research (SPER), Jamia Hamdard (UGC approved deemed to be University, Govt. of India), New Delhi- ۱۱۰۰۶۲, India
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :